Background: Women’s health has historically served as an incubator for major medical innovations yet often faces relative neglect in sustained funding and implementation. The rise of artificial intelligence (AI) and machine learning (ML) presents both opportunities and risks for diagnostics in obstetrics and gynecology (OB/GYN). Methods: A narrative review (January 2018–August 2025) integrating peer-reviewed literature and clinical exemplars was conducted. OB/GYN relevance, clinical validation/scale, near-term outcome impact, and domain diversity were prioritized in selection. Results: We highlight ten promising AI applications across imaging, laboratory diagnostics, patient monitoring/digital biomarkers, and decision support, including AI-enhanced fetal ultrasound, cervical screening, preeclampsia prediction with cell-free RNA, noninvasive endometriosis testing, remote maternal–fetal monitoring, and reinforcement-learning decision support in gynecologic oncology. Conclusions: AI shows transformative potential for women’s health diagnostics but requires attention to bias, privacy, regulatory evolution, reimbursement, and workflow integration. Equity-focused development and diverse datasets are essential to ensure benefits accrue broadly.
Christian Macedonia (2025) studied this question.